Relief Therapeutics

Supporting patients through science and innovation

Pipeline

Relief Therapeutics is a drug development company focusing on clinical stage projects, primarily developing drugs of natural human origin (peptides and proteins) with a history of clinical testing and use in human patients.

Currently Relief Therapeutics concentrates its initial efforts on diabetic complications and respiratory diseases. A focus on additional MPCs and indications will be considered as opportunities develop.

Main development programs I:
Relief places a special emphasis to rapidly deliver on these programs with the highest priority. They constitute the main strategical focus of the company.

main development programs

main development programs

 

Main development programs II:
Although Relief is conscious that these programs have a great potential to benefit patients, in a resource-limited environment Relief has decided to pause development in these indications for now. Relief is committed to look for new resources in order to rapidly resume these programs.

main development programs

main development programs